AllianceBernstein’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

AllianceBernstein’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-375,864	Closed	-$7.5M	–	3373
2022 Q3	$7.5M	Buy	375,864 +333,164	+780%	+$4.39M	﹤0.01%	1209
2022 Q2	$294K	Buy	42,700 +9,600	+29%	+$67.4K	﹤0.01%	2887
2022 Q1	$308K	Buy	33,100 +100	+0.3%	+$1.06K	﹤0.01%	2863
2021 Q4	$469K	Buy	33,000 +3,000	+10%	+$51.9K	﹤0.01%	2774
2021 Q3	$696K	Sell	30,000 -2,300	-7%	-$54.4K	﹤0.01%	2635
2021 Q2	$804K	Buy	32,300 +4,000	+14%	+$107K	﹤0.01%	2624
2021 Q1	$793K	Buy	28,300 +5,100	+22%	+$184K	﹤0.01%	2496
2020 Q4	$810K	Hold	23,200	–	–	﹤0.01%	2390
2020 Q3	$1.16M	Buy	+23,200	New	+$938K	﹤0.01%	2114

AllianceBernstein's FMTX Position: Q4 2022 in Review

AllianceBernstein sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 375,864 shares — an estimated $7.5M sold.

AllianceBernstein first reported a position in FMTX in Q3 2020 and held it in 9 quarters. The position peaked at $7.5M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

AllianceBernstein reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
AllianceBernstein sold 375,864 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $7.5M.
AllianceBernstein first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
AllianceBernstein's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $7.5M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on AllianceBernstein's 13F filing for Q4 2022, filed 15 Feb 2023.